About: Biocon

An Entity of Type: Public company, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Biocon Limited is an Indian biopharmaceutical company that is based in Bangalore, India. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in over 120 countries across the globe, including the developed markets of the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets. Syngene International Limited (Syngene) is a publicly listed subsidiary of Biocon, operating in the contract research services space.

Property Value
dbo:abstract
  • Biocon ist ein indisches, auf Krebs- und Diabetes-mellitus-Medikamente spezialisiertes Biotechnologieunternehmen mit Sitz in Bengaluru. Es steht gemessen am Umsatz auf dem 16. Platz weltweit und ist damit das größte Indiens. Zusätzlich expandiert die Firma mit der Gründung der Tochterfirmen (Molekulare Biotechnologie und Synthetische Chemie) und (Mikrobielle Fermentierung, Biodiversität, Bioprozessierung, Contract Research) in weitere Segmente. Das Unternehmen beschäftigt derzeit 2000 Mitarbeiter, von denen 10 % einen Doktor und 30 % einen Masterabschluss haben; 30 % sind Frauen und das Durchschnittsalter liegt bei 28 Jahren. (de)
  • Biocon Limited is an Indian biopharmaceutical company that is based in Bangalore, India. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in over 120 countries across the globe, including the developed markets of the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets. Syngene International Limited (Syngene) is a publicly listed subsidiary of Biocon, operating in the contract research services space. Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy and nephrology products. Some of Biocon's key brands in India include INSUGEN (rh-insulin), BASALOG (Glargine), BIOMAb EGFR (Nimotuzumab), BLISTO (Glimepiride + Metformin), CANMAb (Trastuzumab), Evertor (Everolimus), TACROGRAF (Tacrolimus), ALZUMAb(Itolizumab) and KRABEVA (Bevacizumab). Biocon and Syngene together employ about 9,200 personnel. (en)
  • Biocon est une entreprise indienne de biotechnologie, basée à Bengalore. Elle est fondée par Kiran Mazumdar-Shaw. Elle est notamment spécialisée dans les enzymes, la fabrication d'insuline ou l'oncologie. (fr)
dbo:foundedBy
dbo:foundingYear
  • 1978-01-01 (xsd:gYear)
dbo:industry
dbo:keyPerson
dbo:numberOfEmployees
  • 9234 (xsd:nonNegativeInteger)
dbo:product
dbo:revenueYear
  • 2021-01-01 (xsd:gYear)
dbo:thumbnail
dbo:type
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 1899802 (xsd:integer)
dbo:wikiPageLength
  • 23253 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1069442879 (xsd:integer)
dbo:wikiPageWikiLink
dbp:assetsYear
  • 2021 (xsd:integer)
dbp:equityYear
  • 2021 (xsd:integer)
dbp:founder
dbp:incomeYear
  • 2021 (xsd:integer)
dbp:industry
dbp:isin
  • INE376G01013 (en)
dbp:keyPeople
  • (en)
  • Kiran Mazumdar-Shaw (en)
  • Siddharth mittal (en)
dbp:locationCity
dbp:locationCountry
dbp:logo
  • Biocon Logo.svg (en)
dbp:name
  • Biocon Limited (en)
dbp:netIncomeYear
  • 2021 (xsd:integer)
dbp:numEmployees
  • 9234 (xsd:integer)
dbp:products
dbp:revenueYear
  • 2021 (xsd:integer)
dbp:subsid
  • (en)
  • Syngene (en)
dbp:type
dbp:wikiPageUsesTemplate
dbp:wordnet_type
dct:subject
gold:hypernym
rdf:type
rdfs:comment
  • Biocon est une entreprise indienne de biotechnologie, basée à Bengalore. Elle est fondée par Kiran Mazumdar-Shaw. Elle est notamment spécialisée dans les enzymes, la fabrication d'insuline ou l'oncologie. (fr)
  • Biocon ist ein indisches, auf Krebs- und Diabetes-mellitus-Medikamente spezialisiertes Biotechnologieunternehmen mit Sitz in Bengaluru. Es steht gemessen am Umsatz auf dem 16. Platz weltweit und ist damit das größte Indiens. Zusätzlich expandiert die Firma mit der Gründung der Tochterfirmen (Molekulare Biotechnologie und Synthetische Chemie) und (Mikrobielle Fermentierung, Biodiversität, Bioprozessierung, Contract Research) in weitere Segmente. (de)
  • Biocon Limited is an Indian biopharmaceutical company that is based in Bangalore, India. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in over 120 countries across the globe, including the developed markets of the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets. Syngene International Limited (Syngene) is a publicly listed subsidiary of Biocon, operating in the contract research services space. (en)
rdfs:label
  • Biocon (de)
  • Biocon (en)
  • Biocon (fr)
owl:sameAs
skos:closeMatch
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
foaf:name
  • Biocon Limited (en)
is dbo:occupation of
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License